Randall W. Knoebel

Pharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients”.

Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients

Journal of Personalized Medicine(2021)10.3390/jpm11121343

N/A

0.307DataRank · unranked

6 citations

Keith Danahey, Merisa Middlestadt, Kevin J. O’Leary, Edith A. Nutescu, Tai C. Chen +16 more

Patient out-of-pocket savings with lower-dose trastuzumab.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18828

N/A

0DataRank · unranked

1 citations

Alec Kacew, Po-Hung Hsieh, Anthony V. Serritella, Randall W. Knoebel, Rita Nanda +3 more

Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings

npj Breast Cancer(2022)10.1038/s41523-022-00393-2

N/A

0DataRank · unranked

21 citations

Alec Kacew, Marie Dreyer, Anthony V. Serritella, Randall W. Knoebel, Garth W. Strohbehn +2 more

Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive CYP2D6 Genotyping in Cancer Palliative Care

Journal of Pain Research(2024)10.2147/jpr.s488416

N/A

0DataRank · unranked

2 citations

Theodore Karrison, Matthew Jack, Anish Choksi, Randall W. Knoebel, Kiang-Teck J Yeo +6 more

Results of the ACCOuNT Trial: A Multi‐Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70024

N/A

0DataRank · unranked

1 citations

Kevin J. O’Leary, Edith A. Nutescu, Matthew Jack, Tai C. Chen, Gregory W. Ruhnke +13 more

Impact of First‐of‐Its‐Kind Patient‐Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3747

N/A

0DataRank · unranked

0 citations

Sami Elahi, Matthew Jack, John Campbell, Emily Smith, Randall W. Knoebel +11 more